栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/09/26 | 1,698 | 1,708 | 1,657 | 1,668 | -16 | -1% | 183,600 |
2019/09/25 | 1,699 | 1,708 | 1,660 | 1,684 | -16 | -0.9% | 114,500 |
2019/09/24 | 1,713 | 1,742 | 1,686 | 1,700 | -13 | -0.8% | 164,800 |
2019/09/20 | 1,730 | 1,752 | 1,712 | 1,713 | +6 | +0.4% | 206,600 |
2019/09/19 | 1,680 | 1,720 | 1,678 | 1,707 | +29 | +1.7% | 164,700 |
2019/09/18 | 1,677 | 1,688 | 1,659 | 1,678 | +12 | +0.7% | 181,700 |
2019/09/17 | 1,627 | 1,678 | 1,625 | 1,666 | +50 | +3.1% | 218,400 |
2019/09/13 | 1,624 | 1,624 | 1,595 | 1,616 | +9 | +0.6% | 225,400 |
2019/09/12 | 1,646 | 1,654 | 1,606 | 1,607 | -31 | -1.9% | 158,900 |
2019/09/11 | 1,620 | 1,639 | 1,615 | 1,638 | +13 | +0.8% | 150,000 |
2019/09/10 | 1,626 | 1,655 | 1,616 | 1,625 | -5 | -0.3% | 152,100 |
2019/09/09 | 1,628 | 1,636 | 1,624 | 1,630 | -3 | -0.2% | 84,500 |
2019/09/06 | 1,629 | 1,640 | 1,621 | 1,633 | +12 | +0.7% | 82,100 |
2019/09/05 | 1,613 | 1,639 | 1,603 | 1,621 | +25 | +1.6% | 167,200 |
2019/09/04 | 1,634 | 1,634 | 1,586 | 1,596 | -51 | -3.1% | 173,000 |
2019/09/03 | 1,588 | 1,667 | 1,583 | 1,647 | +65 | +4.1% | 285,400 |
2019/09/02 | 1,604 | 1,614 | 1,574 | 1,582 | -15 | -0.9% | 178,400 |
2019/08/30 | 1,567 | 1,607 | 1,556 | 1,597 | +39 | +2.5% | 147,900 |
2019/08/29 | 1,545 | 1,559 | 1,530 | 1,558 | +21 | +1.4% | 136,700 |
2019/08/28 | 1,551 | 1,557 | 1,528 | 1,537 | -15 | -1% | 113,100 |
2019/08/27 | 1,526 | 1,570 | 1,524 | 1,552 | +42 | +2.8% | 194,200 |
2019/08/26 | 1,502 | 1,525 | 1,500 | 1,510 | -51 | -3.3% | 186,900 |
2019/08/23 | 1,568 | 1,569 | 1,544 | 1,561 | -8 | -0.5% | 281,800 |
2019/08/22 | 1,613 | 1,614 | 1,563 | 1,569 | -37 | -2.3% | 175,300 |
2019/08/21 | 1,622 | 1,631 | 1,598 | 1,606 | -33 | -2% | 88,200 |
2019/08/20 | 1,634 | 1,644 | 1,620 | 1,639 | +5 | +0.3% | 126,800 |
2019/08/19 | 1,598 | 1,647 | 1,584 | 1,634 | +43 | +2.7% | 168,400 |
2019/08/16 | 1,583 | 1,618 | 1,565 | 1,591 | +9 | +0.6% | 187,800 |
2019/08/15 | 1,591 | 1,613 | 1,578 | 1,582 | -38 | -2.3% | 186,200 |
2019/08/14 | 1,635 | 1,641 | 1,598 | 1,620 | -12 | -0.7% | 304,500 |
2019/08/13 | 1,637 | 1,643 | 1,615 | 1,632 | -27 | -1.6% | 234,000 |
2019/08/09 | 1,709 | 1,716 | 1,655 | 1,659 | -52 | -3% | 204,100 |
2019/08/08 | 1,710 | 1,718 | 1,678 | 1,711 | -16 | -0.9% | 160,100 |
2019/08/07 | 1,720 | 1,730 | 1,702 | 1,727 | -2 | -0.1% | 104,900 |
2019/08/06 | 1,683 | 1,734 | 1,674 | 1,729 | -7 | -0.4% | 152,100 |
2019/08/05 | 1,752 | 1,762 | 1,704 | 1,736 | -37 | -2.1% | 171,000 |
2019/08/02 | 1,771 | 1,805 | 1,758 | 1,773 | -20 | -1.1% | 183,600 |
2019/08/01 | 1,822 | 1,833 | 1,782 | 1,793 | -42 | -2.3% | 170,600 |
2019/07/31 | 1,864 | 1,881 | 1,835 | 1,835 | -49 | -2.6% | 131,700 |
2019/07/30 | 1,850 | 1,884 | 1,834 | 1,884 | +48 | +2.6% | 221,200 |
2019/07/29 | 1,942 | 1,979 | 1,825 | 1,836 | -104 | -5.4% | 474,400 |
2019/07/26 | 1,856 | 1,968 | 1,855 | 1,940 | +80 | +4.3% | 624,700 |
2019/07/25 | 1,865 | 1,940 | 1,845 | 1,860 | +113 | +6.5% | 1,082,800 |
2019/07/24 | 1,710 | 1,748 | 1,702 | 1,747 | +37 | +2.2% | 181,800 |
2019/07/23 | 1,721 | 1,721 | 1,696 | 1,710 | -9 | -0.5% | 159,100 |
2019/07/22 | 1,728 | 1,731 | 1,713 | 1,719 | -18 | -1% | 117,700 |
2019/07/19 | 1,711 | 1,747 | 1,676 | 1,737 | +11 | +0.6% | 182,100 |
2019/07/18 | 1,763 | 1,768 | 1,717 | 1,726 | -38 | -2.2% | 244,200 |
2019/07/17 | 1,760 | 1,785 | 1,753 | 1,764 | +3 | +0.2% | 111,700 |
2019/07/16 | 1,774 | 1,777 | 1,756 | 1,761 | -13 | -0.7% | 78,600 |
1451~
1500
件表示中 / 7029件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 244,100円 | +4.1% | -3.1% | 2.38% | 21.20倍 | 1.85倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
持田薬 | 317,000円 | +5.1% | -7.0% | 2.52% | 20.81倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 204,500円 | +3.1% | -6.5% | 2.35% | 9.49倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 153,500円 | -2.4% | -52.3% | 3.71% | 18.37倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 97,800円 | +20.3% | - | 0.00% | 173.40倍 | 1.34倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム